Horizon Enters into Partnership with Pirbright Institute to Improve Vaccine Yields

News   Apr 16, 2018 | Original story from Horizon

 
Horizon Enters into Partnership with Pirbright Institute to Improve Vaccine Yields
 
 
 

RELATED ARTICLES

New Target for Immunotherapy for Solid Tumors?

News

Research from the University of Cincinnati (UC) reveals a potential new target to help T cells (white blood cells) infiltrate certain solid tumors.

READ MORE

DNA Barcodes Help Track Cells

News

Each of our genomes contains millions of one-letter variations called single nucleotide polymorphisms. Researchers have now developed a technique that utilizes these unique features to track cells from different donors.

READ MORE

Gene-edited Organoids Reveal How Deadly Brain Cancer Grows

News

Glioblastoma multiforme (GBM) is an incredibly deadly brain cancer and presents a serious black box challenge. It's virtually impossible to observe how these tumors operate in their natural environment and animal models don't always provide good answers. Researchers have now taken an important step towards meeting that challenge.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE